Sientra officials celebrate being listed on the Nasdaq after an IPO in October 2014. The bottom has fallen out from under Sientra and the Goleta-based breast implant manufacturer is bleeding cash as it waits for approval to resume production. Exactly one month ago, the company stunned Wall Street with news that regulators found contaminating particles…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
